跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FERINJECT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FERINJECT
Authorized
STANDARD
FERINJECT
Vifor (International) AG
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6a7b277ff2da04c5
Company
Vifor (International) AG
Type
Standard
Approval Details
Approval Id
6a7b277ff2da04c5
Drug Approval Canada Name
FERINJECT
Product Name
FERINJECT
Status
Marketed
Status Date
2024-11-07
Original Market Date
2024-11-07
Din
02546078
Drug Class
Human
Dosage Form
Dispersion
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:04.04
Atc Original
B03AC IRON, PARENTERAL PREPARATIONS
Atc Name
b 03 ac
Aig Number
0108536006
Company Name
Vifor (International) AG
Company Address
Rechenstrasse 37, St. Gallen, St Gallen, Switzerland, 9014
Company Detail Path
/organization/vifor-international-ag
Company Information
Pharmaceutical Company Name
Vifor (International) AG
Name Zh
维福(国际)股份公司
Country Name
Switzerland
Province Name
sankt gallen,country_ch
City Name
st. gallen,sankt gallen,country_ch
Address
Rechenstrasse 37
Website
http://www.vifor.com
Active Ingredients
IRON (FERRIC CARBOXYMALTOSE)
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6a7b277ff2da04c5
Type
Standard
Back to Health Canada Approvals